OSI Pharmaceuticals, LLC et al v. Zydus Pharmaceuticals (USA) Inc.
| Genentech, Inc. and OSI Pharmaceuticals, LLC |
| Zydus Pharmaceuticals (USA) Inc. |
| 1:2019cv00741 |
| April 25, 2019 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 1, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 8 STIPULATION TO EXTEND TIME for defendant to move, plead or otherwise respond to the Complaint to July 29, 2019 - filed by Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) |
SO ORDERED, re #8 STIPULATION TO EXTEND TIME for defendant to move, plead or otherwise respond to the Complaint to July 29, 2019 filed by Zydus Pharmaceuticals (USA) Inc. Set/Reset Answer Deadlines: Zydus Pharmaceuticals (USA) Inc. answer due 7/29/2019. Signed by Judge Colm F. Connolly on 7/1/2019. (fms)
|
| Filing 7 WAIVER OF SERVICE returned executed by OSI Pharmaceuticals, LLC, Genentech, Inc.: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 5/2/2019, answer due 7/1/2019. (Fahnestock, Derek) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc. (ceg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas US LLC for OSI Pharmaceuticals, LLC filed by OSI Pharmaceuticals, LLC. (ceg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,900,221 B1. (ceg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/15/2019. Date of Expiration of Patent: 5/9/2021.Thirty Month Stay Deadline: 9/15/2021. (ceg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2627794.) - filed by OSI Pharmaceuticals, LLC, Genentech, Inc. (Attachments: #1 Exhibits A-B, #2 Civil Cover Sheet)(ceg) |
| Summons Issued with Magistrate Consent Notice attached as to Zydus Pharmaceuticals (USA) Inc. on 4/25/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
